{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:24:23Z","timestamp":1761895463715},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.juro.2012.01.082","type":"journal-article","created":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T13:02:33Z","timestamp":1334149353000},"page":"2061-2067","source":"Crossref","is-referenced-by-count":12,"title":["Prostate Specific Antigen Levels and Prostate Cancer Detection Rates in Patients With End Stage Renal Disease"],"prefix":"10.1097","volume":"187","author":[{"given":"Catherine J.","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Urology, Loma Linda University Medical Center, Loma Linda, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan P.","family":"Heldt","sequence":"additional","affiliation":[{"name":"Department of Urology, Loma Linda University Medical Center, Loma Linda, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk M.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Urology, Loma Linda University Medical Center, Loma Linda, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert C.","family":"Ruckle","sequence":"additional","affiliation":[{"name":"Department of Urology, Loma Linda University Medical Center, Loma Linda, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautum","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Urology, Loma Linda University Medical Center, Loma Linda, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien L.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Urology, Loma Linda University Medical Center, Loma Linda, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy E.","family":"Schlaifer","sequence":"additional","affiliation":[{"name":"Department of Urology, Loma Linda University Medical Center, Loma Linda, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon D.","family":"Richards","sequence":"additional","affiliation":[{"name":"Department of Urology, Loma Linda University Medical Center, Loma Linda, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don C.","family":"Arnold","sequence":"additional","affiliation":[{"name":"Department of Urology, Loma Linda University Medical Center, Loma Linda, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Duane","family":"Baldwin","sequence":"additional","affiliation":[{"name":"Department of Urology, Loma Linda University Medical Center, Loma Linda, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2012.01.082_bib1","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1093\/ndt\/17.12.2212","article-title":"Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991\u20132001","volume":"17","author":"McDonald","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.juro.2012.01.082_bib2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.transproceed.2010.12.015","article-title":"Assessment of health-related quality of life in renal transplant recipients and dialysis patients","volume":"43","author":"Maglakelidze","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.juro.2012.01.082_bib3","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.transproceed.2009.06.176","article-title":"Survival of patients older than 60 years with kidneys transplanted from Spanish expanded criteria donors versus patients continued on hemodialysis","volume":"41","author":"Martin Navarro","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.juro.2012.01.082_bib4","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1600-6135.2005.00831.x","article-title":"Trends and results for organ donation and transplantation in the United States, 2004","volume":"5","author":"Port","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.juro.2012.01.082_bib5","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2012.01.082_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: an international collaborative study","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.juro.2012.01.082_bib7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000132701","article-title":"Prevalence of prostate cancer in end-stage renal disease patients","volume":"80","author":"Kamata","year":"2008","journal-title":"Urol Int"},{"key":"10.1016\/j.juro.2012.01.082_bib8","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jama.1993.03510070082041","article-title":"Serum prostate-specific antigen in a community-based population of healthy men","volume":"270","author":"Oesterling","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2012.01.082_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jnci\/dji065","article-title":"Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial","volume":"97","author":"Andriole","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2012.01.082_bib10","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.1997.03540420048028","article-title":"Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng\/mL and benign prostate examination","volume":"277","author":"Catalona","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2012.01.082_bib11","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","article-title":"Measurement of prostate-specific antigen in serum as a screening test for prostate cancer","volume":"324","author":"Catalona","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2012.01.082_bib12","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0022-5347(17)37402-5","article-title":"Serum prostate specific antigen as pre-screening test for prostate cancer","volume":"147","author":"Labrie","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.01.082_bib13","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.urology.2005.05.025","article-title":"Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng\/mL: observation and clinical implications from Tyrol screening project","volume":"66","author":"Pelzer","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.juro.2012.01.082_bib14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2012.01.082_bib15","first-page":"452","article-title":"Screening for prostate cancer with PSA testing: current status and future directions","volume":"25","author":"Croswell","year":"2011","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.juro.2012.01.082_bib16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.eururo.2006.07.052","article-title":"Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam","volume":"51","author":"de Vries","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.01.082_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","article-title":"Cancer statistics, 2004","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.juro.2012.01.082_bib18","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.juro.2009.01.021","article-title":"Prostate cancer screening and treatment in the transplant population: current status and recommendations","volume":"181","author":"Breyer","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.01.082_bib19","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.urology.2009.05.100","article-title":"Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen","volume":"76","author":"Joseph","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.juro.2012.01.082_bib20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1464-410X.1995.tb07272.x","article-title":"Influence of end-stage renal disease and renal transplantation on serum prostate-specific antigen","volume":"75","author":"Morton","year":"1995","journal-title":"Br J Urol"},{"key":"10.1016\/j.juro.2012.01.082_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-5347(01)63039-8","article-title":"Serum levels of total and free prostate specific antigen in men on hemodialysis","volume":"160","author":"Sasagawa","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.01.082_bib22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/00365590701226002","article-title":"Effect of hemodialysis on serum complexed prostate-specific antigen levels","volume":"41","author":"Tarhan","year":"2007","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.juro.2012.01.082_bib23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/18.3.598","article-title":"Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment","volume":"18","author":"Bruun","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.juro.2012.01.082_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11912-010-0136-x","article-title":"Prostate cancer screening","volume":"13","author":"Cook","year":"2011","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.juro.2012.01.082_bib25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11255-007-9246-2","article-title":"Screening for prostate cancer using prostate-specific antigen testing in Japanese men on hemodialysis","volume":"40","author":"Kurahashi","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.juro.2012.01.082_bib26","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.2215\/CJN.00310107","article-title":"Comparison of stage at diagnosis of cancer in patients who are on dialysis versus the general population","volume":"2","author":"Taneja","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.juro.2012.01.082_bib27","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1093\/ndt\/gfn008","article-title":"Prostate cancer in renal transplant recipients","volume":"23","author":"Kleinclauss","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.juro.2012.01.082_bib28","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1089\/end.2010.0680","article-title":"Patients with end-stage renal disease are candidates for robot-assisted laparoscopic radical prostatectomy","volume":"25","author":"Heldt","year":"2011","journal-title":"J Endourol"},{"key":"10.1016\/j.juro.2012.01.082_bib29","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1097\/01.TP.0000137933.97259.E7","article-title":"Three-dimensional conformal radiotherapy for localized prostate cancer in kidney transplant recipients","volume":"78","author":"Mouzin","year":"2004","journal-title":"Transplantation"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712002133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712002133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2012.01.082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T02:21:33Z","timestamp":1651198893000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2012.01.082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.1016\/j.juro.2012.01.082"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2012.01.082","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}